Societe Generale’s Elevance Health ELV Stock Holding History

Societe Generale’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.29M	Buy	+9,792	New	+$1.34M	0.01%	1137

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Societe Generale's ELV Position: Q2 2016 in Review

Societe Generale opened a new position in Elevance Health (ELV) in Q2 2016: 9,792 shares worth $1.29M. The stake represents 0.01% of the portfolio and ranks #1137 among its holdings.

759 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

Societe Generale held 9,792 shares of Elevance Health worth $1.29M as of Q2 2016.
Elevance Health was a new Societe Generale position in Q2 2016.
Elevance Health made up 0.01% of Societe Generale's portfolio in Q2 2016, its #1137 holding.
759 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.